Episode 489: Big Heart Health News You'll Want To Know About
About this episode
Dr. Kahn shares updates from the American College of Cardiology meeting on heart health and related topics.
This week, Dr. Kahn shares exciting updates from the American College of Cardiology meeting, highlighting several new trials focused on reducing heart events in patients with diabetes and those with established heart disease. The results are promising and could help prevent strokes, heart attacks, and even save lives. Additional topics include vegan diets and cancer risk, heart disease in police officers, the link between Alzheimer's disease and statins, concerns around erythritol sweeteners, Lp(a) levels in stent patients, niacin for fatty liver disease, and the role of beta blockers after heart attacks. This episode is brought to you by Igennus Healthcare Nutrition—formulators of high-quality, science-backed supplements designed for optimal absorption and effectiveness. Their products are rigorously tested and trusted by health professionals worldwide. Visit igennus.com and use code DrKahn to save on your order.
People in this episode
Host: Dr. Joel Kahn
Topics covered
- heart health
- diabetes
- vegan diets
- cancer risk
- heart disease
- Alzheimer's disease
- supplements
Sponsors
Igennus Healthcare Nutrition
Mentioned in this episode
Organizations: American College of Cardiology
Products: erythritol sweeteners, niacin
Places: Alzheimer's disease
More episodes of Heart Doc VIP with Dr. Joel Kahn
- Episode 493: The Top 3 Dietary Predictors of Cardiac Death Worldwide
- Episode 492: Does the Shingles Vaccine Reduce Heart and Brain Disease?
- Episode 491: Heart Disease in Masters Athletes: What to Do?
- Episode 490: My Surgical Journey 2 Weeks Later
- Bonus Episode: Why a CIMT Ultrasound Is a Must-Have Examination with Joseph Ence
- Episode 487: The Role of Diet, Blood Pressure, and Hormones in Dementia
Explore listener stats, chart rankings, contacts and more on the Heart Doc VIP with Dr. Joel Kahn podcast page.